Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma

Taku Fujimura, Takanori Hidaka, Yumi Kambayashi, Sadanori Furudate, Aya Kakizaki, Hisayuki Tono, Akira Tsukada, Takahiro Haga, Akira Hashimoto, Ryo Morimoto, Takuhiro Yamaguchi, Tadao Takano, Setsuya Aiba

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences